Gregory J. Riely
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma(2011)4,802 cited
- → Tumor mutational load predicts survival after immunotherapy across multiple cancer types(2019)4,299 cited
- → Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain(2005)3,519 cited
- → Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients(2017)3,455 cited
- → Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer(2013)3,387 cited
- → OncoKB: A Precision Oncology Knowledge Base(2017)2,642 cited
- → Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers(2013)2,447 cited
- → Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer(2014)1,981 cited
- → MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)1,584 cited
- → KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib(2005)1,521 cited